spacer
spacer
header
Main Menu
Home
Search
Donate
About OPN
Contact Us
Membership
OPAN
News
Event Calendar
Projects
FREE Cannabis
Jury Power
Medical Maps
Speakers
OPN on the Radio
Legal
Media
Patient/Doctor
Patient Profiles
Online Store
Library
Links
FAQs
Interactive
Email Discussion
Teamspeak
MySpace
OPNTalk Forums
OPNews
OPNews Signup
Recent Issues
Archives
Video
Mikeee Show
Ohio Patients Imprisoned
Randy Brush
In Memoriam
 
Home arrow News arrow OPNews June 2006 arrow Evaluation of a vaporizing device (Volcano®) for pulmonary administration of tetrahydrocannabinol

Evaluation of a vaporizing device (Volcano®) for pulmonary administration of tetrahydrocannabinol PDF Print E-mail

Abstract: What is currently needed for optimal use of medicinal cannabinoids is a feasible, nonsmoked, rapid-onset delivery system. Cannabis "vaporization" is a technique aimed at suppressing irritating respiratory toxins by heating cannabis to a temperature where active cannabinoid vapors form, but below the point of combustion where smoke and associated toxins are produced. The goal of this study was to evaluate the performance of the Volcano vaporizer in terms of reproducible delivery of the bioactive cannabinoid tetrahydrocannabinol (THC) by using pure cannabinoid preparations, so that it could be used in a clinical trial. By changing parameters such as temperature setting, type of evaporation sample and balloon volume, the vaporization of THC was systematically improved to its maximum, while preventing the formation of breakdown products of THC, such as cannabinol or delta-8-THC. Inter- and intra-device variability was tested as well as relationship between loaded- and delivered dose. It was found that an average of about 54% of loaded THC was delivered into the balloon of the vaporizer, in a reproducible manner. When the vaporizer was used for clinical administration of inhaled THC, it was found that on average 35% of inhaled THC was directly exhaled again. Our results show that with the Volcano a safe and effective cannabinoid delivery system seems to be available to patients. The final pulmonal uptake of THC is comparable to the smoking of cannabis, while avoiding the respiratory disadvantages of smoking. © 2006 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 95:1308-1317, 2006

Clinical trial published in the Journal of Pharmaceutical Sciences calls the Volcano Vaporizer a "safe and effective" cannabinoid delivery system:

"The goal of this study was to evaluate the performance of the Volcano vaporizer in terms of reproducible delivery of the bioactive cannabinoid tetrahydrocannabinol (THC) by using pure cannabinoid preparations, so that it could be used in a clinical trial. ... Our results show that with the Volcano a safe and effective cannabinoid delivery system seems to be available to patients. The final pulmonal uptake of THC is comparable to the smoking of cannabis, while avoiding the respiratory disadvantages of smoking."

spacer
Join/Donate
via Paypal
GoodSearch: You Search...We Give!
Ohio Medical Marijuana Act

Please contact your legislators regarding the Ohio Medical Marijuana Act!

The Zoretic Patient Defense Fund
To donate to the Zoretic Patient Defense Fund, OPN's patient legal defense fund, simply click the above button. Before entering the amount, please indicate that your donation is for the Zoretic Patient Defense Fund in the Payment For: text box. Thank you for your contribution!

Advertisement
War on Junk
A riotous exploration of prohibition policies, told through the narrative lens of a future America in which the government outlaws junk food in response to widespread obesity. Click on the image to buy this book now. 10% of the purchase price will be donated to OPN.

 
Copyright 2000 - 2005 Miro International Pty Ltd. All rights reserved.
Mambo is Free Software released under the GNU/GPL License.
spacer